Clinical Trials Browser

Phase 3 × INDUSTRY × Dermatologic × Clear all

Melanoma, Cutaneous Malignant

Skin Neoplasms

Melanoma, Skin Neoplasms

Keratosis, Actinic

Melanoma, Skin Neoplasms

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Cutaneous Squamous Cell Carcinoma

Keratosis, Neoplasms, Precancerous Conditions, Keratosis, Actinic

Precancerous Conditions, Skin Diseases, Keratosis, Actinic

Uveal Melanoma, Eye Neoplasms

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Diseases, Skin Neoplasms

Melanoma, Nevus, Blue

Precancerous Conditions, Skin Diseases, Keratosis, Actinic

Uveal Melanoma, Melanoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

Melanoma, Neoplasm Metastasis

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

Melanoma, Neoplasm Metastasis

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

Basal Cell Nevus Syndrome

Brain Neoplasms, Melanoma

Melanoma, Skin Neoplasms

Keratosis, Actinic

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Merkel Cell

Melanoma, Skin Neoplasms

Fever, Melanoma

Bowen's Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Warts, Keratosis, Actinic

Keratosis, Actinic

Clinical Trials

SUPRAME

CheckMate76K

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

FLASH2

Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma

A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma

TirbAKare

MK-3475-054

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

CoMpass

COLUMBUS

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Neoadjuvant Darovasertib in Primary Uveal Melanoma

LEAP-003

Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma

A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

RELATIVITY-098

LEAP-003

Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

NeoDREAM

MAVIS

KEYVIBE-010

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

V940-001

COMBI-i

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

RELATIVITY-127

EXACT-1

OH2 Injection in Melanoma

Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

NEO-MIMAJOR

UNIVERSE

KEYNOTE-913

Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

COMBI-APlus

CheckMate 238

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up